Search

everythinglearnresearchcommunity

for

Search:↓

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

The patient with a misplaced pituitary gland and interrupted pituitary stalk is being treated with hormone replacement.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

Human liver enzyme DHEA ST helps process minoxidil.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Compounds in fluted pumpkin and African yam bean seed oils may help manage benign prostate hyperplasia.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Dexamethasone reduces inflammation and delays skin cell changes caused by TPA.

Oral minoxidil can be improved for hair loss treatment with personalized strategies and new technologies.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Four-amino acid part makes enzyme sensitive to finasteride.

A new compound was made that might help treat diseases related to male hormones.

The new microneedle treatment could be a more effective and convenient option for hair loss.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Neurosteroids help control dopamine responses in the brain.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Chitosan-coated dutasteride nanocapsules improve hair treatment, and physical stimulation boosts effectiveness.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

SEPA™ enhances the effectiveness of minoxidil in stimulating hair growth, working faster and better than Rogaine® TS, with no significant side effects.